152 related articles for article (PubMed ID: 18374168)
1. Invasion and metastasis models for studying RhoGDI2 in bladder cancer.
Nitz MD; Harding MA; Theodorescu D
Methods Enzymol; 2008; 439():219-33. PubMed ID: 18374168
[TBL] [Abstract][Full Text] [Related]
2. Expression profile of RhoGDI2 in lung cancers and role of RhoGDI2 in lung cancer metastasis.
Niu H; Li H; Xu C; He P
Oncol Rep; 2010 Aug; 24(2):465-71. PubMed ID: 20596634
[TBL] [Abstract][Full Text] [Related]
3. RhoGDIbeta lacking the N-terminal regulatory domain suppresses metastasis by promoting anoikis in v-src-transformed cells.
Ota T; Maeda M; Sakita-Suto S; Zhou X; Murakami M; Takegami T; Tatsuka M
Clin Exp Metastasis; 2006; 23(7-8):323-34. PubMed ID: 17111235
[TBL] [Abstract][Full Text] [Related]
4. Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia.
Wu Y; McRoberts K; Berr SS; Frierson HF; Conaway M; Theodorescu D
Oncogene; 2007 Feb; 26(5):765-73. PubMed ID: 16878152
[TBL] [Abstract][Full Text] [Related]
5. Src phosphorylation of RhoGDI2 regulates its metastasis suppressor function.
Wu Y; Moissoglu K; Wang H; Wang X; Frierson HF; Schwartz MA; Theodorescu D
Proc Natl Acad Sci U S A; 2009 Apr; 106(14):5807-12. PubMed ID: 19321744
[TBL] [Abstract][Full Text] [Related]
6. Rho GDP dissociation inhibitor 2 suppresses metastasis via unconventional regulation of RhoGTPases.
Moissoglu K; McRoberts KS; Meier JA; Theodorescu D; Schwartz MA
Cancer Res; 2009 Apr; 69(7):2838-44. PubMed ID: 19276387
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of Rho GDP dissociation inhibitor 2 in colorectal carcinoma.
Fujita A; Shida A; Fujioka S; Kurihara H; Okamoto T; Yanaga K
Int J Clin Oncol; 2012 Apr; 17(2):137-42. PubMed ID: 21698524
[TBL] [Abstract][Full Text] [Related]
8. The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines.
Seraj MJ; Harding MA; Gildea JJ; Welch DR; Theodorescu D
Clin Exp Metastasis; 2000; 18(6):519-25. PubMed ID: 11592309
[TBL] [Abstract][Full Text] [Related]
9. Pathways of metastasis suppression in bladder cancer.
Said N; Theodorescu D
Cancer Metastasis Rev; 2009 Dec; 28(3-4):327-33. PubMed ID: 20013033
[TBL] [Abstract][Full Text] [Related]
10. RhoGDI2 as a therapeutic target in cancer.
Cho HJ; Baek KE; Yoo J
Expert Opin Ther Targets; 2010 Jan; 14(1):67-75. PubMed ID: 20001211
[TBL] [Abstract][Full Text] [Related]
11. RhoC Is an Unexpected Target of RhoGDI2 in Prevention of Lung Colonization of Bladder Cancer.
Griner EM; Dancik GM; Costello JC; Owens C; Guin S; Edwards MG; Brautigan DL; Theodorescu D
Mol Cancer Res; 2015 Mar; 13(3):483-92. PubMed ID: 25516960
[TBL] [Abstract][Full Text] [Related]
12. Endothelin axis is a target of the lung metastasis suppressor gene RhoGDI2.
Titus B; Frierson HF; Conaway M; Ching K; Guise T; Chirgwin J; Hampton G; Theodorescu D
Cancer Res; 2005 Aug; 65(16):7320-7. PubMed ID: 16103083
[TBL] [Abstract][Full Text] [Related]
13. Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer.
Theodorescu D; Sapinoso LM; Conaway MR; Oxford G; Hampton GM; Frierson HF
Clin Cancer Res; 2004 Jun; 10(11):3800-6. PubMed ID: 15173088
[TBL] [Abstract][Full Text] [Related]
14. RhoGDI2: a new metastasis suppressor gene: discovery and clinical translation.
Harding MA; Theodorescu D
Urol Oncol; 2007; 25(5):401-6. PubMed ID: 17826660
[TBL] [Abstract][Full Text] [Related]
15. RhoGDI2 is an invasion and metastasis suppressor gene in human cancer.
Gildea JJ; Seraj MJ; Oxford G; Harding MA; Hampton GM; Moskaluk CA; Frierson HF; Conaway MR; Theodorescu D
Cancer Res; 2002 Nov; 62(22):6418-23. PubMed ID: 12438227
[TBL] [Abstract][Full Text] [Related]
16. RhoGDI2 expression is associated with tumor growth and malignant progression of gastric cancer.
Cho HJ; Baek KE; Park SM; Kim IK; Choi YL; Cho HJ; Nam IK; Hwang EM; Park JY; Han JY; Kang SS; Kim DC; Lee WS; Lee MN; Oh GT; Kim JW; Lee CW; Yoo J
Clin Cancer Res; 2009 Apr; 15(8):2612-9. PubMed ID: 19351766
[TBL] [Abstract][Full Text] [Related]
17. RhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration.
Said N; Sanchez-Carbayo M; Smith SC; Theodorescu D
J Clin Invest; 2012 Apr; 122(4):1503-18. PubMed ID: 22406535
[TBL] [Abstract][Full Text] [Related]
18. XIAP overexpression promotes bladder cancer invasion in vitro and lung metastasis in vivo via enhancing nucleolin-mediated Rho-GDIβ mRNA stability.
Yu Y; Jin H; Xu J; Gu J; Li X; Xie Q; Huang H; Li J; Tian Z; Jiang G; Chen C; He F; Wu XR; Huang C
Int J Cancer; 2018 May; 142(10):2040-2055. PubMed ID: 29250796
[TBL] [Abstract][Full Text] [Related]
19. The faces and friends of RhoGDI2.
Griner EM; Theodorescu D
Cancer Metastasis Rev; 2012 Dec; 31(3-4):519-28. PubMed ID: 22718398
[TBL] [Abstract][Full Text] [Related]
20. VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance.
Cho HJ; Kim IK; Park SM; Baek KE; Nam IK; Park SH; Ryu KJ; Choi J; Ryu J; Hong SC; Jeong SH; Lee YJ; Ko GH; Kim J; Won Lee C; Soo Kang S; Yoo J
Int J Cancer; 2014 Oct; 135(7):1553-63. PubMed ID: 24585459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
